miR-145 suppresses tumor angiogenesis, growth and invasion by lowering the production of the oncogene VEGF-A and by suppressing the expression of the serine/threonine kinase p70S6K1, which promotes HIF-1α and VEGF activities in colon cancer cells [46,47]. Here, VEGFA is linked to colonic neoplasm.